JOHNATHAN C BAINES

Allopathic & Osteopathic Physicians|Family Medicine RUSTON, LA NPI 1679769889

General Payments — all program years on this page

$3,676.49

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 234
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $400.80 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $400.8021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $583.3034
2019 $282.3019
2020 $401.4430
2021 $513.7932
2022 $712.8847
2023 $781.9851
2024 $400.8021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086259964 Bayer Healthcare Pharmaceuticals Inc. $13.66 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086266525 Bayer Healthcare Pharmaceuticals Inc. $16.13 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096711350 Novo Nordisk Inc $19.46 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096916800 Novo Nordisk Inc $19.20 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097034209 Novo Nordisk Inc $13.24 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103265891 ABBVIE INC. $23.25 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103265893 ABBVIE INC. $22.83 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103265895 ABBVIE INC. $24.37 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111522823 Amgen Inc. $19.58 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111522825 Amgen Inc. $23.91 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111522827 Amgen Inc. $17.79 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114583321 Exact Sciences Corporation $20.68 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117768310 Corcept Therapeutics $23.97 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117768342 Corcept Therapeutics $20.26 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127780023 EVOKE PHARMA, INC. $16.17 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135060975 Lilly USA, LLC $13.86 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135061731 Lilly USA, LLC $16.82 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135091863 Lilly USA, LLC $21.76 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141971135 Merck Sharp & Dohme LLC $15.00 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147304706 Mylan Specialty L.P. $23.99 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153743610 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.87 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.